Bob Tirva

Insider profile

Currently holds positions in Resonant Inc and DNA X Inc

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Resonant Inc Oct. 11, 2018 -
Interim Chief Financial Officer DNA X Inc Sept. 10, 2019 -
Senior Vice President, Principal Accounting Officer, Corporate Controller Broadcom Corp Feb. 1, 2010 - Sept. 26, 2014
Bob Tirva's trades of DNA X Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US DNA X Inc (SONM)
Transaction date
Sale
Price
195.80
Quantity 57,312 +33.5%
Value US$4,905,546
US DNA X Inc (SONM)
Transaction date
Sale
Price
485.86
Quantity 10,494 -21.1%
Value US$1,261,174
US DNA X Inc (SONM)
Transaction date
Sale
Price
331.37
Quantity 88,758 +37.4%
Value US$1,570,298
US DNA X Inc (SONM)
Transaction date
Sale
Price
0.58
Quantity 4,493 -1.3%
Value US$2,583
US DNA X Inc (SONM)
Transaction date
Sale
Price
0.67
Quantity 6,417 -0.6%
Value US$4,299
US DNA X Inc (SONM)
Transaction date
Planned sale
Price
0.64
Quantity 42,891 -5.6%
Value US$27,450
US DNA X Inc (SONM)
Transaction date
Sale
Price
0.86
Quantity 7,826 -1.1%
Value US$6,695
US DNA X Inc (SONM)
Transaction date
Purchase
Price
0.75
Quantity 100,000 +15.5%
Value US$75,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-07-15 2022-07-15
US DNA X Inc (SONM)
S Sale
57,312 +33.5%
195.80
US$4,905,546 		57,312 +33.5% 195.80 US$4,905,546
2022-07-15 2022-07-13
US DNA X Inc (SONM)
S Sale
10,494 -21.1%
485.86
US$1,261,174 		10,494 -21.1% 485.86 US$1,261,174
2022-06-22 2022-06-21
US DNA X Inc (SONM)
S Sale
88,758 +37.4%
331.37
US$1,570,298 		88,758 +37.4% 331.37 US$1,570,298
2022-06-13 2022-06-10
US DNA X Inc (SONM)
S Sale
4,493 -1.3%
0.58
US$2,583 		4,493 -1.3% 0.58 US$2,583
2021-09-14 2021-09-10
US DNA X Inc (SONM)
S Sale
6,417 -0.6%
0.67
US$4,299 		6,417 -0.6% 0.67 US$4,299
2021-06-11 2021-06-10
US DNA X Inc (SONM)
PlS Planned sale
42,891 -5.6%
0.64
US$27,450 		42,891 -5.6% 0.64 US$27,450
2020-09-14 2020-09-10
US DNA X Inc (SONM)
S Sale
7,826 -1.1%
0.86
US$6,695 		7,826 -1.1% 0.86 US$6,695
2020-06-11 2020-06-09
US DNA X Inc (SONM)
B Purchase
100,000 +15.5%
0.75
US$75,000 		100,000 +15.5% 0.75 US$75,000